Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

FRA:33L - Deutsche Boerse Ag - US5500211090 - Common Stock - Currency: EUR

310.6  -10.35 (-3.22%)

Fundamental Rating

7

33L gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 42 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making 33L a very profitable company, without any liquidiy or solvency issues. 33L shows excellent growth, but is valued quite expensive already. These ratings would make 33L suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
33L had a positive operating cash flow in the past year.
Each year in the past 5 years 33L has been profitable.
Each year in the past 5 years 33L had a positive operating cash flow.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

33L has a better Return On Assets (24.50%) than 100.00% of its industry peers.
With an excellent Return On Equity value of 43.55%, 33L belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
33L's Return On Invested Capital of 30.48% is amongst the best of the industry. 33L outperforms 100.00% of its industry peers.
33L had an Average Return On Invested Capital over the past 3 years of 27.36%. This is significantly above the industry average of 10.98%.
The last Return On Invested Capital (30.48%) for 33L is above the 3 year average (27.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 24.5%
ROE 43.55%
ROIC 30.48%
ROA(3y)18.95%
ROA(5y)18.12%
ROE(3y)33.12%
ROE(5y)31.09%
ROIC(3y)27.36%
ROIC(5y)24.43%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

33L has a Profit Margin of 17.05%. This is amongst the best in the industry. 33L outperforms 93.18% of its industry peers.
33L's Profit Margin has improved in the last couple of years.
33L's Operating Margin of 23.35% is amongst the best of the industry. 33L outperforms 88.64% of its industry peers.
33L's Operating Margin has been stable in the last couple of years.
33L has a Gross Margin of 58.85%. This is comparable to the rest of the industry: 33L outperforms 54.55% of its industry peers.
In the last couple of years the Gross Margin of 33L has remained more or less at the same level.
Industry RankSector Rank
OM 23.35%
PM (TTM) 17.05%
GM 58.85%
OM growth 3Y5.93%
OM growth 5Y1.38%
PM growth 3Y6.4%
PM growth 5Y1.84%
GM growth 3Y1.37%
GM growth 5Y1.09%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 33L is creating value.
Compared to 1 year ago, 33L has less shares outstanding
Compared to 5 years ago, 33L has less shares outstanding
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

33L has an Altman-Z score of 11.53. This indicates that 33L is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.53, 33L belongs to the top of the industry, outperforming 95.45% of the companies in the same industry.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.53
ROIC/WACC3.53
WACC8.64%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.00 indicates that 33L should not have too much problems paying its short term obligations.
33L's Current ratio of 2.00 is fine compared to the rest of the industry. 33L outperforms 75.00% of its industry peers.
33L has a Quick Ratio of 1.00. This is a normal value and indicates that 33L is financially healthy and should not expect problems in meeting its short term obligations.
33L's Quick ratio of 1.00 is fine compared to the rest of the industry. 33L outperforms 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

7

3. Growth

3.1 Past

33L shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.48%, which is quite good.
Measured over the past years, 33L shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.05% on average per year.
33L shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.84%.
Measured over the past years, 33L shows a very strong growth in Revenue. The Revenue has been growing by 23.95% on average per year.
EPS 1Y (TTM)16.48%
EPS 3Y40.07%
EPS 5Y27.05%
EPS Q2Q%13.44%
Revenue 1Y (TTM)10.84%
Revenue growth 3Y29.77%
Revenue growth 5Y23.95%
Sales Q2Q%8.73%

3.2 Future

33L is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.26% yearly.
The Revenue is expected to grow by 8.58% on average over the next years. This is quite good.
EPS Next Y14.17%
EPS Next 2Y10.52%
EPS Next 3Y10.47%
EPS Next 5Y12.26%
Revenue Next Year9.76%
Revenue Next 2Y8.37%
Revenue Next 3Y8.44%
Revenue Next 5Y8.58%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.34, the valuation of 33L can be described as rather expensive.
33L's Price/Earnings ratio is a bit cheaper when compared to the industry. 33L is cheaper than 61.36% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, 33L is valued at the same level.
With a Price/Forward Earnings ratio of 21.60, 33L is valued on the expensive side.
Based on the Price/Forward Earnings ratio, 33L is valued a bit cheaper than 68.18% of the companies in the same industry.
33L's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 24.34
Fwd PE 21.6
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

33L's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 33L is more expensive than 63.64% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 33L is valued a bit more expensive than the industry average as 70.45% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 25.75
EV/EBITDA 14.27
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

33L's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
33L has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.72
PEG (5Y)0.9
EPS Next 2Y10.52%
EPS Next 3Y10.47%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (3/7/2025, 7:00:00 PM)

310.6

-10.35 (-3.22%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)06-03 2025-06-03/amc
Inst Owners92.02%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap37.82B
Analysts76.59
Price Target392.57 (26.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.06%
Min EPS beat(2)4.71%
Max EPS beat(2)5.41%
EPS beat(4)4
Avg EPS beat(4)4.57%
Min EPS beat(4)3.64%
Max EPS beat(4)5.41%
EPS beat(8)8
Avg EPS beat(8)5.58%
EPS beat(12)11
Avg EPS beat(12)5.14%
EPS beat(16)15
Avg EPS beat(16)8.54%
Revenue beat(2)0
Avg Revenue beat(2)-1.86%
Min Revenue beat(2)-3.46%
Max Revenue beat(2)-0.26%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-3.46%
Max Revenue beat(4)-0.26%
Revenue beat(8)2
Avg Revenue beat(8)-0.7%
Revenue beat(12)5
Avg Revenue beat(12)-0.07%
Revenue beat(16)8
Avg Revenue beat(16)0.79%
PT rev (1m)4.56%
PT rev (3m)26.18%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)4.24%
EPS NY rev (1m)0.01%
EPS NY rev (3m)2.71%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)2.45%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 24.34
Fwd PE 21.6
P/S 4.03
P/FCF 25.75
P/OCF 18.21
P/B 10.3
P/tB 10.79
EV/EBITDA 14.27
EPS(TTM)12.76
EY4.11%
EPS(NY)14.38
Fwd EY4.63%
FCF(TTM)12.06
FCFY3.88%
OCF(TTM)17.06
OCFY5.49%
SpS77.01
BVpS30.15
TBVpS28.8
PEG (NY)1.72
PEG (5Y)0.9
Profitability
Industry RankSector Rank
ROA 24.5%
ROE 43.55%
ROCE 45.03%
ROIC 30.48%
ROICexc 39.33%
ROICexgc 41.13%
OM 23.35%
PM (TTM) 17.05%
GM 58.85%
FCFM 15.66%
ROA(3y)18.95%
ROA(5y)18.12%
ROE(3y)33.12%
ROE(5y)31.09%
ROIC(3y)27.36%
ROIC(5y)24.43%
ROICexc(3y)42.27%
ROICexc(5y)38.4%
ROICexgc(3y)46.02%
ROICexgc(5y)42.26%
ROCE(3y)40.41%
ROCE(5y)36.09%
ROICexcg growth 3Y11.07%
ROICexcg growth 5Y-7.81%
ROICexc growth 3Y20.21%
ROICexc growth 5Y-7.3%
OM growth 3Y5.93%
OM growth 5Y1.38%
PM growth 3Y6.4%
PM growth 5Y1.84%
GM growth 3Y1.37%
GM growth 5Y1.09%
F-Score7
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 158.75%
Cap/Sales 6.49%
Interest Coverage 250
Cash Conversion 80.73%
Profit Quality 91.88%
Current Ratio 2
Quick Ratio 1
Altman-Z 11.53
F-Score7
WACC8.64%
ROIC/WACC3.53
Cap/Depr(3y)188.88%
Cap/Depr(5y)173.01%
Cap/Sales(3y)6.99%
Cap/Sales(5y)6.66%
Profit Quality(3y)82.13%
Profit Quality(5y)80.74%
High Growth Momentum
Growth
EPS 1Y (TTM)16.48%
EPS 3Y40.07%
EPS 5Y27.05%
EPS Q2Q%13.44%
EPS Next Y14.17%
EPS Next 2Y10.52%
EPS Next 3Y10.47%
EPS Next 5Y12.26%
Revenue 1Y (TTM)10.84%
Revenue growth 3Y29.77%
Revenue growth 5Y23.95%
Sales Q2Q%8.73%
Revenue Next Year9.76%
Revenue Next 2Y8.37%
Revenue Next 3Y8.44%
Revenue Next 5Y8.58%
EBIT growth 1Y17.95%
EBIT growth 3Y37.46%
EBIT growth 5Y25.66%
EBIT Next Year31.06%
EBIT Next 3Y13.94%
EBIT Next 5Y12.01%
FCF growth 1Y1633.42%
FCF growth 3Y42.01%
FCF growth 5Y26.04%
OCF growth 1Y246.36%
OCF growth 3Y41.92%
OCF growth 5Y25.32%